Minnesota Partnership for Biotechnology and Medical Genomics

To position Minnesota in the forefront of biomedical research, the University of Minnesota, the Mayo Clinic, and the state of Minnesota created the Minnesota Partnership for Biotechnology and Medical Genomics. This new collaboration brings together Minnesota’s two renowned research institutions, which collectively manage major research projects amounting to $700 million in funding, a figure that has been substantially rising during the last few years.

The partnership, announced in April 2003, represents a commitment from both institutions to unite on biotechnology and medical genomics research projects, leveraging their scientific and research strengths. The second part of the venture was securing the involvement of the state of Minnesota.

The partnership initially will aim for advances in biotechnology and medical genomics that have the potential to create breakthroughs in scientific understanding and patient treatments for cancer, heart disease, and neurological diseases. Over the long term the partnership is expected to contribute to Minnesota’s economy by stimulating new businesses, creating quality jobs, and expanding the tax base.

For more information,

• Visit the Minnesota Partnership for Biotechnology and Medical Genomics Web site.